Sarepta Therapeutics, Inc. at Morgan Stanley Global Healthcare Conference Transcript
Good morning, everyone, and thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Mike Ulz, one of the biotech analysts here, and it's my pleasure to introduce the team from Sarepta Therapeutics. To my left, Michael Severino, CEO, and to his left is James Richardson, the CMO.
Just a reminder, the format for today is a fireside chat, but if anyone in the audience has a question, please raise your hand and we can try and address it in our discussion. But before we get started, I just need to read a quick disclaimer. For important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.
And with that, I'll turn it over to Michael to make some introductory comments, and then we can hop into the Q&A.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
